-- Israeli Stocks: Leumi, Teva, BioLineRx, EZchip, Allot, Redhill
-- B y   S h o s h a n n a   S o l o m o n
-- 2012-02-12T16:28:53Z
-- http://www.bloomberg.com/news/2012-02-12/israeli-stocks-leumi-teva-biolinerx-ezchip-allot-redhill.html
Israel ’s  TA-25 index  advanced 0.4
percent to 1,121 at the 5 p.m. close in  Tel Aviv . The close was
delayed after the bourse opened an hour late as a general strike
that shut the exchange for two days ended. Investors traded
about 720 million shekels ($193 million) of shares and
convertible securities, according to bourse data.  The following stocks rose or fell today. Symbols are in
parentheses.  Allot Communications Ltd. (ALLT)  (ALLT IT) tumbled 9.4 percent,
the most since Oct. 2, to 61.19 shekels or the equivalent of
$16.44. The Israeli maker of high-speed networking equipment’s
U.S.-traded shares closed at $16.13 in  New York  on Feb. 10.  BioLineRX Ltd. (BLRX)   retreated 8.3 percent to 1.522
shekels or the equivalent of 41 cents, the lowest close since
Jan. 31. The biopharmaceutical company’s ADRs, each representing
10 shares, closed at $3.93 in New York last week.  EZchip Semiconductor Ltd. (EZCH)   soared to the highest
on record, jumping 12 percent to 138.50 shekels, or $37.22.  The
U.S-traded shares of the processor maker closed at $37.06.  Bank Leumi Le-Israel Ltd. (LUMI)   advanced 2.8 percent,
the most since Jan. 26, to 12.28 shekels. The board of the
country’s largest lender by assets approved measures that will
cut costs by as much as 400 million shekels a year.  Perrigo Co. (PRGO)   lost 4.4 percent, the most since Oct.
30, to 349.80 shekels, or the equivalent of $94. The New York-
traded shares of the largest U.S. maker of generic over-the-
counter drugs, closed at $93.31.  Redhill Biopharma Ltd. (RDHL)  (RDHL IT) advanced 2.8 percent, the
most since Jan. 19, to 2.201 shekels. The biopharmaceutical
company received U.S. Food and Drug Administration approval for
a clinical trial of its RHB-102 drug against nausea and vomiting
in cancer treatments.  Teva Pharmaceutical Industries Ltd. (TEVA)   declined to
the lowest since Jan. 3, retreating 1.7 percent to 165.60
shekels, or $44.50. The U.S.-traded shares of the world’s
biggest maker of generic drugs closed at $44.16.  To contact the reporter on this story:
Shoshanna Solomon in Tel Aviv at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  